FI104896B - Menetelmä 1,4,5-trisubstituoidun-3-hydroksi-pyridiniumyhdisteen valmistamiseksi - Google Patents
Menetelmä 1,4,5-trisubstituoidun-3-hydroksi-pyridiniumyhdisteen valmistamiseksi Download PDFInfo
- Publication number
- FI104896B FI104896B FI930367A FI930367A FI104896B FI 104896 B FI104896 B FI 104896B FI 930367 A FI930367 A FI 930367A FI 930367 A FI930367 A FI 930367A FI 104896 B FI104896 B FI 104896B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- group
- acid
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Soft Magnetic Materials (AREA)
- Paper (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929202139A GB9202139D0 (en) | 1992-01-31 | 1992-01-31 | Improvements in or relating to organic compounds |
| GB9202139 | 1992-01-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI930367A0 FI930367A0 (fi) | 1993-01-28 |
| FI930367A FI930367A (fi) | 1993-08-01 |
| FI104896B true FI104896B (fi) | 2000-04-28 |
Family
ID=10709643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI930367A FI104896B (fi) | 1992-01-31 | 1993-01-28 | Menetelmä 1,4,5-trisubstituoidun-3-hydroksi-pyridiniumyhdisteen valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0556152B1 (de) |
| JP (1) | JP3544549B2 (de) |
| AT (1) | ATE210645T1 (de) |
| AU (1) | AU663909B2 (de) |
| CA (1) | CA2088396A1 (de) |
| CZ (1) | CZ288038B6 (de) |
| DE (1) | DE69331293T2 (de) |
| DK (1) | DK0556152T3 (de) |
| ES (1) | ES2169723T3 (de) |
| FI (1) | FI104896B (de) |
| GB (1) | GB9202139D0 (de) |
| HU (1) | HU214677B (de) |
| NO (1) | NO180779C (de) |
| PT (1) | PT556152E (de) |
| SG (1) | SG43065A1 (de) |
| SK (1) | SK281137B6 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5620861A (en) * | 1992-07-31 | 1997-04-15 | Metra Biosystems, Inc. | Method and kit for pyridinium crosslink assay |
| US5736344A (en) * | 1992-12-17 | 1998-04-07 | Metra Biosystems, Inc. | Serum pyridinium crosslinks assay |
| US5756361A (en) * | 1992-12-17 | 1998-05-26 | Metra Biosystems, Inc. | Screening method for periodontal disease |
| US5661039A (en) * | 1995-03-01 | 1997-08-26 | Metra Biosystems, Inc. | Perspiration assay for bone resorption |
| US5723619A (en) * | 1997-01-13 | 1998-03-03 | Bayer Corporation | Method for the synthesis of deoxypyridinoline |
| US5834610A (en) * | 1997-05-06 | 1998-11-10 | Johnson; Gary M. | Conversion of pyridinoline to deoxypyridinoline |
| CN105801688A (zh) * | 2016-04-14 | 2016-07-27 | 苏州博源医疗科技有限公司 | 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59148766A (ja) * | 1983-02-10 | 1984-08-25 | Otsuka Pharmaceut Co Ltd | ピリジン誘導体 |
| US4973666A (en) * | 1987-11-06 | 1990-11-27 | Washington Research Foundation | Peptide fragments containing HP and LP cross-links |
| GB8929366D0 (en) * | 1989-12-30 | 1990-02-28 | Rowett Research Inst | Method to detect connective tissue disorder in humans and animals |
-
1992
- 1992-01-31 GB GB929202139A patent/GB9202139D0/en active Pending
-
1993
- 1993-01-15 HU HU9300108A patent/HU214677B/hu not_active IP Right Cessation
- 1993-01-26 PT PT93810049T patent/PT556152E/pt unknown
- 1993-01-26 DE DE69331293T patent/DE69331293T2/de not_active Expired - Fee Related
- 1993-01-26 SG SG1996003175A patent/SG43065A1/en unknown
- 1993-01-26 AT AT93810049T patent/ATE210645T1/de not_active IP Right Cessation
- 1993-01-26 DK DK93810049T patent/DK0556152T3/da active
- 1993-01-26 ES ES93810049T patent/ES2169723T3/es not_active Expired - Lifetime
- 1993-01-26 EP EP93810049A patent/EP0556152B1/de not_active Expired - Lifetime
- 1993-01-28 NO NO930284A patent/NO180779C/no unknown
- 1993-01-28 SK SK42-93A patent/SK281137B6/sk unknown
- 1993-01-28 FI FI930367A patent/FI104896B/fi active
- 1993-01-29 CZ CZ1993106A patent/CZ288038B6/cs not_active IP Right Cessation
- 1993-01-29 AU AU32105/93A patent/AU663909B2/en not_active Ceased
- 1993-01-29 JP JP01341493A patent/JP3544549B2/ja not_active Expired - Fee Related
- 1993-01-29 CA CA002088396A patent/CA2088396A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO930284D0 (no) | 1993-01-28 |
| SK4293A3 (en) | 1993-11-10 |
| AU3210593A (en) | 1993-08-05 |
| HUT70276A (en) | 1995-09-28 |
| PT556152E (pt) | 2002-05-31 |
| GB9202139D0 (en) | 1992-03-18 |
| HU214677B (hu) | 1998-04-28 |
| CA2088396A1 (en) | 1993-08-01 |
| CZ288038B6 (cs) | 2001-04-11 |
| DE69331293D1 (de) | 2002-01-24 |
| EP0556152B1 (de) | 2001-12-12 |
| ATE210645T1 (de) | 2001-12-15 |
| ES2169723T3 (es) | 2002-07-16 |
| FI930367A (fi) | 1993-08-01 |
| NO930284L (no) | 1993-08-02 |
| JPH0641078A (ja) | 1994-02-15 |
| HU9300108D0 (en) | 1993-04-28 |
| FI930367A0 (fi) | 1993-01-28 |
| JP3544549B2 (ja) | 2004-07-21 |
| AU663909B2 (en) | 1995-10-26 |
| EP0556152A1 (de) | 1993-08-18 |
| NO180779C (no) | 1997-06-18 |
| SK281137B6 (sk) | 2000-12-11 |
| SG43065A1 (en) | 1997-10-17 |
| DE69331293T2 (de) | 2002-07-18 |
| NO180779B (no) | 1997-03-10 |
| CZ10693A3 (en) | 1993-12-15 |
| DK0556152T3 (da) | 2002-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3327551B2 (ja) | 流体試料中のチロキシンを検出・定量するための試薬および方法 | |
| AU2011224719B2 (en) | Lenalidomide and thalidomide immunoassays | |
| AU2010284614B2 (en) | Imatinib immunoassay | |
| JP2015096549A (ja) | リスペリドンイムノアッセイ | |
| AU2013305904A1 (en) | Antibodies to quetiapine haptens and use thereof | |
| AU2013305895A1 (en) | Antibodies to olanzapine haptens and use thereof | |
| CN104854110A (zh) | 奥氮平半抗原 | |
| JP2016510413A (ja) | 分子の検出のための光又は化学解離性コンジュゲート | |
| AU2013305935A1 (en) | Haptens of quetiapine for use in immunoassays | |
| CA2586511A1 (en) | Immunoassays for lamotrigine | |
| US8846411B2 (en) | Derivatives, reagents, and immunoassay for detecting levetiracetam | |
| FI104896B (fi) | Menetelmä 1,4,5-trisubstituoidun-3-hydroksi-pyridiniumyhdisteen valmistamiseksi | |
| WO2008145609A1 (en) | Method of making covalent conjugates with his-tagged proteins | |
| EP0931062B1 (de) | Konjugate und spezifische immuntests des methadonmetaboliten 2-ethylidin-1,5-dimethyl-3,3-diphenyl-3,3-diphenylpyrrolidin | |
| KR100259761B1 (ko) | 에스에이치기 표지용시약, 그의 제조방법 및 이를 이용한 표지법 | |
| CA2216880A1 (en) | Reagents and methods for the detection and quantification of vancomycin in biological fluids | |
| Adamczyk et al. | Synthesis of immunocomponents for the measurement of lead (Pb) by fluorescence polarization immunoassay | |
| US6175016B1 (en) | Pyridine derivatives | |
| JPH09249662A (ja) | アクリジン誘導体、その製法およびこれを用いた標識法 | |
| Fagbure | Small Molecule Inhibitors of the Endoplasmic Reticulum Associated Degradation Pathway | |
| Bailey et al. | Strategies For Increasing The Sensitivity of N-Terminal Sequence Analysis | |
| EP0265496A1 (de) | Flecainid-Derivate und deren Verwendung in Immuntestverfahren. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |